NSF International: Press Releases

Upcoming Webinar: Nitrosamine Impurities; What’s the Impact on IMPs
Monday, September 21, 2020

An Update on Remote and Virtual Auditing
Monday, August 24, 2020

New Edition of NSF’s Health Sciences Journal Now Live!
Tuesday, August 18, 2020

NSF Launches New IVD App!
Wednesday, July 08, 2020 NSF International announces the release of its new in vitro diagnostics (IVD) app, available on Apple’s App Store and Android’s Google Play. This free app is full of useful...

NSF now offering live instructor-led virtual pharmaceutical and medical devices training
Friday, May 22, 2020 NSF has transformed their traditional classroom teaching style and is now offering virtual instructor-led training courses for pharmaceutical and medical devices.

Upcoming complimentary webinar: Clinical Investigations – Transitioning From MDD to MDR
Friday, March 13, 2020 On 17 March, NSF will present a complimentary webinar on clinical investigations, providing an overview of the regulatory requirements for clinical studies.

NSF International expands Health Sciences Group with acquisition of majority interest in Amarex CRO
Friday, February 07, 2020 The transaction creates a single access point for medical device and pharma/biotech product developers seeking integrated, expert services throughout the entire product life cycle.

NSF International EVP Kim Trautman appointed to Regulatory Affairs Professionals Society Board
Friday, February 07, 2020 Trautman joins a team of global leaders guiding the independent, non-profit organisation supporting and leading the profession through an increasingly complex regulatory environment.

Privacy Policy
We have updated our privacy policy. In the latest update it explains what cookies are and how we use them on our site. To learn more about cookies and their benefits, please view our privacy policy. Please be aware that parts of this site will not function correctly if you disable cookies. By continuing to use this site, you consent to our use of cookies in accordance with our privacy policy unless you have disabled them.